These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Liver disorders in patients receiving chlorpromazine or isoniazid. Derby LE; Gutthann SP; Jick H; Dean AD Pharmacotherapy; 1993; 13(4):353-8. PubMed ID: 8361861 [TBL] [Abstract][Full Text] [Related]
7. Oral contraceptives and liver damage under experimental conditions. Beskid M; Ruźyllo E Mater Med Pol; 1977; 9(3):210-5. PubMed ID: 926835 [No Abstract] [Full Text] [Related]
13. Alteration of cephalin-cholesterol flocculation in patients taking oral contraceptive agents. Keidan H Can Med Assoc J; 1966 May; 94(19):1014. PubMed ID: 4952387 [No Abstract] [Full Text] [Related]
14. [The hepatic lesions of medicinal origin]. Berthelot P; Sicot C; Fauvert R Rein Foie; 1970; 13():Suppl B:31+. PubMed ID: 5511039 [No Abstract] [Full Text] [Related]
15. Intrahepatic cholestasis with jaundice after taking contraceptive steroids. von Oldershausen HF; Eggstein M; Dold U; Knörr K Ger Med Mon; 1966 Jan; 11(1):24-8. PubMed ID: 5933450 [No Abstract] [Full Text] [Related]
16. Oral contraceptives and the liver. Br Med J; 1966 Jun; 1(5502):1499. PubMed ID: 5941497 [No Abstract] [Full Text] [Related]
17. The effect of oral contraceptives on the liver. Schaffner F JAMA; 1966 Nov; 198(9):1019-21. PubMed ID: 5332484 [No Abstract] [Full Text] [Related]
18. [Hepatic function and oral ovulostatic drugs]. Conti M; Neglia V Ann Ostet Ginecol Med Perinat; 1968 Aug; 90(8):554-60. PubMed ID: 5740536 [No Abstract] [Full Text] [Related]